Human Genome (HGSI) Could Become Takeover Target Upon Approval of Benlysta

Go back to Human Genome (HGSI) Could Become Takeover Target Upon Approval of Benlysta
Abbott Laboratories (NYSE: ABT) Delayed: 106.47 +0.95 (0.90%)
Previous Close $105.52    52 Week High $46.38 
Open $105.69    52 Week Low $36.00 
Day High $106.86    P/E 70.98 
Day Low $104.78    EPS $1.50 
Volume 1,417,929       

Amgen Inc (NASDAQ: AMGN) Delayed: 393.77 +0.60 (0.15%)
Previous Close $393.17    52 Week High $176.85 
Open $393.07    52 Week Low $133.64 
Day High $395.55    P/E 59.30 
Day Low $389.28    EPS $6.64 
Volume 837,737       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 48.87 +0.33 (0.68%)
Previous Close $48.54    52 Week High $45.58 
Open $48.82    52 Week Low $37.82 
Day High $49.16    P/E N/A 
Day Low $48.60    EPS $0.00 
Volume 882,979       

Human Genome Sciences, Inc. (NASDAQ: HGSI) Delayed: 14.24 --0 (-0%)
Previous Close $14.24    52 Week High $16.58 
Open $55.80    52 Week Low $6.51 
Day High $14.24    P/E N/A 
Day Low $14.24    EPS $-1.79 
Volume 557,147       

Johnson & Johnson (NYSE: JNJ) Delayed: 268.70 -0.42 (0.16%)
Previous Close $269.12    52 Week High $126.07 
Open $268.51    52 Week Low $94.28 
Day High $270.10    P/E 55.86 
Day Low $267.10    EPS $4.81 
Volume 1,336,930       

Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 53.71 -0.36 (0.67%)
Previous Close $54.07    52 Week High $35.13 
Open $54.07    52 Week Low $28.10 
Day High $54.29    P/E N/A 
Day Low $53.48    EPS $0.00 
Volume 779,636